Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
about
Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivoFlip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applicationsGene therapy for malignant glioma.Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.Oncolytic viral therapies.Transcriptional targeting of herpes simplex virus for cell-specific replication.Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro.Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapyOncolytic viral therapy of malignant gliomaMolecular neurosurgery: vectors and vector delivery strategies.Oncolytic Virotherapy for the Treatment of Malignant Glioma.Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolatesRationale and Design of a Phase 1 Clinical Trial to Evaluate HSV G207 Alone or with a Single Radiation Dose in Children with Progressive or Recurrent Malignant Supratentorial Brain Tumors.Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses.Susceptibility of a herpes simplex virus ribonucleotide reductase null mutant to deoxyribonucleosides and antiviral nucleoside analogs.
P2860
Q24519029-D3C8FAA8-840C-42D7-AD78-B45720DB0C0DQ30826113-2E62E528-4E59-4369-A1C9-79B0403729C8Q33995752-DFF592DF-F5E0-482A-B6E5-898C72465F0CQ35673628-A83325EB-F3CE-471F-8AC0-2B5A2EB8EE8EQ35796504-8B366BA9-67B6-429E-90D9-1A3E46D78F62Q35852258-3D08E60F-221D-45C1-A9B7-3BC987E60B88Q35887944-473CA00E-0CB1-43C5-9F0B-905112004095Q36633711-6308C236-3567-46ED-8A8A-935754C94C4AQ36644898-5DA7043A-1F79-4E92-9E0A-AC855F2C4E0CQ37533665-942F8DFA-C4A3-4F85-902F-4C975A12F089Q37998570-D211B907-E824-41B8-BD6C-B26822C9BFF2Q38749871-8C99C084-830C-4534-82C5-1ECBC9A71E83Q39873322-A725C328-0981-4763-959E-991897431931Q40284855-83D38BB4-B356-4441-B041-D91E4E3CF663Q41919532-713FA53A-8AED-4C24-A25A-690CFBB7CA5DQ45861349-907931CD-BFBC-462F-83DD-8D294EB2C041
P2860
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
description
1989 nî lūn-bûn
@nan
1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
@ast
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
@en
type
label
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
@ast
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
@en
prefLabel
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
@ast
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
@en
P2093
P2860
P356
P1476
Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.
@en
P2093
D J Goldstein
S K Weller
P2860
P304
P356
10.1128/AAC.33.8.1395
P407
P577
1989-08-01T00:00:00Z